CinCor Pharma Inc.

NASDAQ: CINC · Real-Time Price · USD
29.06
0.00 (0.00%)
At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
-42.51M
Interest Income
21.64K
Pretax Income
-50.37M
Net Income
-50.35M
Selling & General & Admin
21M
Research & Development
21.51M
Other Expenses
n/a
Operating Expenses
42.51M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
42.51M
Income Tax Expense
-21.64K
Shares Outstanding (Basic)
35.42M
Shares Outstanding (Diluted)
35.42M
EPS (Basic)
-1.42
EPS (Diluted)
-1.42
EBITDA
-34.63M
EBIT
-42.51M
Depreciation & Amortization
7.88M